Articles

• Search by keyword
• Search by citation

10 result(s) for 'Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.' within Virology Journal

1. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

   Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.

   Authors: Martin J Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah and Stuart T Nichol

   Citation: Virology Journal 2005 2:69

   Content type: Research Published on: 22 August 2005

   • View Full Text
   • View PDF

2. A study on the effect of natural products against the transmission of B.1.1.529 Omicron

   The recent outbreak of the Coronavirus pandemic resulted in a successful vaccination program launched by the World Health Organization. However, a large population is still unvaccinated, leading to the emergen...

   Authors: Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, Heba Bedair, Mahmoud Abdo, Soumya Ghosh, Sara Samy Elkafas, Wilgince Apollon, Morteza Saki, Samah A. Loutfy, Helen Onyeaka and Mohamed Hessien

   Citation: Virology Journal 2023 20:191

   Content type: Review Published on: 25 August 2023

   • View Full Text
   • View PDF

   

3. SARS-CoV-2: characteristics and current advances in research

   Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has spread rapidly across the world and become an international public health emergency. Both SARS-CoV-2 and SARS-CoV belong to subfamily Coronav...

   Authors: Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, Xiaoen He, Bo Sun, Zhiran Qin, Jianghai Yu, Jinxiu Yao, Qinghua Wu, Zhang Bao and Wei Zhao

   Citation: Virology Journal 2020 17:117

   Content type: Review Published on: 29 July 2020

   • View Full Text
   • View PDF

4. Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

   The COVID-19 pandemic has put healthcare infrastructures and our social and economic lives under unprecedented strain. Effective solutions are needed to end the pandemic while significantly lessening its furth...

   Authors: Lennox Chitsike and Penelope Duerksen-Hughes

   Citation: Virology Journal 2021 18:154

   Content type: Review Published on: 23 July 2021

   • View Full Text
   • View PDF

5. An overview on the treatments and prevention against COVID-19

   The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While COVID-19 is asymptomatic in most individuals, it can caus...

   Authors: Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, Fatemeh Beiraghdar, Abolfazl Akbarzadeh, Vahideh Tarhriz and Hassan Mellatyar

   Citation: Virology Journal 2023 20:23

   Content type: Review Published on: 8 February 2023

   • View Full Text
   • View PDF

6. Precision therapeutic targets for COVID-19

   Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS-CoV-2 has infected more than 111 mi...

   Authors: Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd E. Golde, Benoit I. Giasson and Yuxing Xia

   Citation: Virology Journal 2021 18:66

   Content type: Review Published on: 29 March 2021

   • View Full Text
   • View PDF

7. Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting

   The rise of the highly lethal severe acute respiratory syndrome-2 (SARS-2) as corona virus 2019 (COVID-19) reminded us of the history of other pandemics that happened in the last century (Spanish flu) and stay...

   Authors: Walid F. Elkhatib, Shereen S. Abdelkareem, Wafaa S. Khalaf, Mona I. Shahin, Dounia Elfadil, Alaa Alhazmi, Ahmed I. El-Batal and Gharieb S. El-Sayyad

   Citation: Virology Journal 2022 19:167

   Content type: Review Published on: 24 October 2022

   • View Full Text
   • View PDF

   

8. Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model

   Coronavirus disease 2019 is a global pandemic caused by SARS-CoV-2. The emergence of its variant strains has posed a considerable challenge to clinical treatment. Therefore, drugs capable of inhibiting SARS-Co...

   Authors: Cuiling Zhang, Bingjie Wei, Zirui Liu, Wei Yao, Yiquan Li, Jing Lu, Chenchen Ge, Xiaoyang Yu, Dapeng Li, Yilong Zhu, Chao Shang, Ningyi Jin and Xiao Li

   Citation: Virology Journal 2023 20:18

   Content type: Research Published on: 31 January 2023

   • View Full Text
   • View PDF

9. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents

   Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel coronavirus that emerged in China in December 2019 and was dec...

   Authors: Sumanth Khadke, Nayla Ahmed, Nausheen Ahmed, Ryan Ratts, Shine Raju, Molly Gallogly, Marcos de Lima and Muhammad Rizwan Sohail

   Citation: Virology Journal 2020 17:154

   Content type: Review Published on: 15 October 2020

   • View Full Text
   • View PDF

10. What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms

    Coronavirus disease 19 (COVID-19) is the disease caused by SARS-CoV-2, a highly infectious member of the coronavirus family, which emerged in December 2019 in “Wuhan, China”. It induces respiratory illness ran...

    Authors: Sawsan Aboul-Fotouh, Ahmed Nageh Mahmoud, Esraa M. Elnahas, Mohamed Z. Habib and Sahar M. Abdelraouf

    Citation: Virology Journal 2023 20:241

    Content type: Review Published on: 24 October 2023

    • View Full Text
    • View PDF